Migrena sa aurom i TKD bubble test: značaj pozitivnog rezultata

  • Ana Podgorac Faculty of Medicine, University of Belgrade, Belgrade, Serbia
  • Jasna Zidverc-Trajković Faculty of Medicine, University of Belgrade, Belgrade, Serbia; Neurology Clinic, Clinical Center of Serbia, Belgrade, Serbia
  • Zagorka Jovanović Faculty of Medicine, University of Belgrade, Belgrade, Serbia; Neurology Clinic, Clinical Center of Serbia, Belgrade, Serbia
  • Aleksandra Radojičić Neurology Clinic, Clinical Center of Serbia, Belgrade, Serbia
  • Aleksandra Pavlović Faculty of Medicine, University of Belgrade, Belgrade, Serbia; Neurology Clinic, Clinical Center of Serbia, Belgrade, Serbia
  • Milija Mijajlović Faculty of Medicine, University of Belgrade, Belgrade, Serbia; Neurology Clinic, Clinical Center of Serbia, Belgrade, Serbia
  • Tamara Švabić-Medjedović Faculty of Medicine, University of Belgrade, Belgrade, Serbia;
  • Nadežda Čovičković-Šternić Faculty of Medicine, University of Belgrade, Belgrade, Serbia; Neurology Clinic, Clinical Center of Serbia, Belgrade, Serbia
Ključne reči: migraine with aura||, ||migrena sa aurom, ultrasonography, doppler, transcranial||, ||ultrasonografija, dopler transkranijumska, diagnosis||, ||dijagnoza,

Sažetak


Uvod/Cilj. Udruženost desno-levog šanta (right-to-left shunt – RLS) i migrene sa aurom (MA) je poznata. Cilj ove studije bio je da se odredi da li prisustvo RLS otkriveno transkranijalnim doplerom (transcranial doppler – TCD) utiče na kliničku sliku, auru i glavobolju bolesnika sa MA. Metode. Ova deskriptivna studija sprovedena je na grupi od 153 bolesnika sa MA. Test TCD bubble test urađen je kod njih 135. Demografske i kliničke karakteristike bolesnika analizirane su i upoređene sa rezultatima TCD bubble testa. Rezutalti. Od 135 bolesnika, kod 88 (65,2%) TCD bubble test bio je pozitivan. Nije utvrđena razlika u ispitivanim kliničkim osobinama bolesnika i aure kod bolesnika sa i bez RLS. Zaključak. Rezultatima ove studije potvrđena je visoka prevalencija RLS kod bolesnika sa MA. Klinička značajnost ove udruženosti, međutim, nije utvrđena.

Reference

Del Sette M, Angeli S, Leandri M, Ferriero G, Bruzzone GL, Finocchi C, et al. Migraine with aura and right-to-left shunt on transcranial Doppler: a case-control study. Cerebrovasc Dis 1998; 8(6): 327−30.

Anzola GP, Magoni M, Guindani M, Rozzini L, Dalla VG. Poten-tial source of cerebral embolism in migraine with aura: a tran-scranial Doppler study. Neurology 1999; 52(8): 1622−5.

Dalla Volta G, Guindani M, Zavarise P, Griffini S, Pezzini A, Pa-dovani A. Prevalence of patent foramen ovale in a large series of patients with migraine with aura, migraine without aura and cluster headache, and relationship with clinical phenotype. J Headache Pain 2005; 6(4): 328−30.

Schwerzmann M, Nedeltchev K, Lagger F, Mattle HP, Windecker S, Meier B, et al. Prevalence and size of directly detected patent foramen ovale in migraine with aura. Neurology 2005; 65(9): 1415−8.

Van Gent MW, Mager JJ, Snijder RJ, Westermann CJ, Plokker HW, Schonewille WJ, et al. Relation between migraine and size of echocardiographic intrapulmonary right-to-left shunt. J Cardiol 2011; 107(9): 1399−404.

Chambers J, Seed PT, Ridsdale L. Association of migraine aura with patent foramen ovale and atrial septal aneurysms. Int J Cardiol 2013; 168(4): 3949−53.

Bousser MG. Patent foramen ovale and migraine: evidence for a Link? Head Curr 2006; 3: 44−51.

Carod-Artal FJ, da Silveira RL, Braga H, Kummer W, Mesquita HM, Vargas AP. Prevalence of patent foramen ovale in mi-graine patients with and without aura compared with stroke patients. A transcranial Doppler study. Cephalalgia 2006; 26(8): 934−9.

Tembl J, Lago A, Sevilla T, Solis P, Vilchez J. Migraine, patent fo-ramen ovale and migraine triggers. J Headache Pain 2007; 8(1): 7−12.

Dowson AJ, Wilmshurst P, Muir KW, Mullen M, Prospective NS. Multicenter, Randomized, Double Blind, Placebo-Controlled Trial to Evaluate the Efficacy of Patent Foramen Ovale Clo-sure with the STARFlex Septal Repair Implant to Prevent Re-fractory Migraine Headaches: the MIST Trial. Circulation 2008; 117(11): 1397−404.

Moussouttas M, Fayad P, Rosenblatt M, Hashimoto M, Pollak J, Henderson K, et al. Pulmonary arteriovenous malformations: cerebral ischemia and neurologic manifestations. Neurology 2000; 55(7): 959−64.

White RI, Lynch-Nyhan A, Terry P, Buescher PC, Farmlett EJ, Charnas L,et al. Pulmonary arteriovenous malformations: tech-niques and long-term outcome of embolotherapy. Radiology 1988; 169(3): 663−9.

Post MC, Letteboer TG, Mager JJ, Plokker TH, Kelder JC, Wester-mann CJ, et al. A pulmonary right-to-left shunt in patients with hereditary hemorrhagic telangiectasia is associated with an in-creased prevalence of migraine. Chest 2005; 128(4): 2485−9.

Headache Classification Subcommittee of the International Headache So-ciety. The International Classification of Headache Disorders. Cephalalgia 2004; 24(Suppl 1): 9−160.

Lao A, Fuller JC, Jesurum TJ. Transcranial Doppler in the detec-tion and quantitation of patent foramen ovale and other right-to-left circulatory shunts. In: Alexandrov A, editor. Cerebrovas-cular ultrasound in stroke prevention and treatment. 2nd ed. Malden, MA: Wiley-Blackwell; 2011. p. 187−97.

Spencer M, Moehring M, Jesurum J, Gray W, Olsen J, Reisman M. Power M-Mode Transcranial Doppler for Diagnosis of Patent Foramen Ovale and Assessing Transcatheter Closure. J Neu-roimaging 2004; 14(4): 342−9.

Domitrz I, Mieszkowski J, Kamińska A. Relationship Between Migraine and Patent Foramen Ovale: A Study of 121 Patients with Migraine. Headache 2007; 47(9): 1311−8.

Wilmshurst PT, Pearson MJ, Nightingale S, Walsh KP, Morrison WL. Inheritance of persistent foramen ovale and atrial septal defects and the relation to familial migraine with aura. Heart 2004; 90(11): 1315−20.

Schürks M, Rist PM, Bigal ME, Buring JE, Lipton RB, Kurth T. Migraine and cardiovascular disease: systematic review and meta-analysis. BMJ 2009; 339(27): 3914.

Objavljeno
2015/11/02
Broj časopisa
Rubrika
Originalni članak